FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
M. Oliveira, C. Saura, P. Nuciforo, I. Calvo, J. Andersen, J.L. Passos-Coelho, M. Gil Gil, B. Bermejo, D.A. Patt, E. Ciruelos, L. de la Peña, N. Xu, M. Wongchenko, Z. Shi, S.M. Singel, S.J. Isakoff.
Manuscrito
Annals of oncology
2019
FAIRLANE
